Advertisement
Advertisement
TENX
Tenax Therapeutics, Inc.
11.66
USDSponsored
+0.01
+0.09%
May 08, 16:00 UTC -4
Closed
Pre-Market
11.83
+0.17
+1.46%
TENX Earnings Reports
Positive Surprise Ratio
TENX beat 21 of 38 last estimates.
55%
Next Report
Tomorrow
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/-$0.40
Implied change from Q4 25 (Revenue/ EPS)
--
/+5.26%
Implied change from Q1 25 (Revenue/ EPS)
--
/+42.86%
Tenax Therapeutics, Inc. earnings per share and revenue
On Mar 10, 2026, TENX reported earnings of -0.38 USD per share (EPS) for Q4 25, beating the estimate of -0.42 USD, resulting in a 10.23% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +31.67% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.40 USD, with revenue projected to reach -- USD, implying an increase of 5.26% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.38
Actual
-$0.45
Surprise
-16.10%
Bicara Therapeutics Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$0.66
Actual
-$0.93
Surprise
-39.98%
Certara, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
$0.10
Actual
$0.09
Surprise
-17.36%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
PUMA BIOTECHNOLOGY INC
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.13
Actual
-$0.04
Surprise
+69.83%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
Apogee Therapeutics, Inc. Common Stock
Report Date
May 11, 2026 For Q1 26
Estimate
-$1.12
Actual
-$1.06
Surprise
+5.65%
Edgewise Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.49
Actual
-$0.46
Surprise
+7.33%
FAQ
What were Tenax Therapeutics, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Tenax Therapeutics, Inc. reported EPS of -$0.38, beating estimates by 10.23%, and revenue of $0.00, 0% as expectations.
How did the market react to Tenax Therapeutics, Inc.'s Q4 2025 earnings?
The stock price moved up 31.67%, changed from $11.02 before the earnings release to $14.51 the day after.
When is Tenax Therapeutics, Inc. expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Tenax Therapeutics, Inc.'s next earnings report?
Based on 4
analysts, Tenax Therapeutics, Inc. is expected to report EPS of -$0.40 and revenue of -- for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement